Mar 13 (Reuters) - Brightpath Biotherapeutics Co., Ltd. PARENT- ONLY EARNINGS ESTIMATES (in billions of yen unless specified) Full Year to Full Year to Mar 31, 2026 Mar 31, 2026 LATEST PREVIOUS FORECAST FORECAST Sales 0 mln 0 mln Operating loss 1.32 loss 1.18 Recurring loss 1.31 loss 1.16 Net loss 1.31 loss 1.17 EPS loss 11.75 yen loss 12.88 yen NOTE - Brightpath Biotherapeutics Co., Ltd.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T